Chris M. Storgard
Chief Medical OfficerDr. Chris M. Storgard, M.D., is Chief Medical Officer of Design Therapeutics, Inc. from April 16,2025. He was Chief Medical Officer of ADARx Pharmaceuticals, Inc. from April 2024. He was Chief Medical Officer at Heron Therapeutics, Inc. since December 2019 and served as Senior Vice President of Clinical Development from joining it in November 2018 until December 2019. Dr. Storgard was a Consultant of Fate Therapeutics, Inc. since November 5, 2018 until December 31, 2018. Dr. Storgard was Chief Medical Officer of Fate Therapeutics, Inc. since May 17, 2016 until November 5, 2018. Dr. Storgard has more than two decades of experience in clinical drug development. He served as an integral member of the executive team at Ardea Biosciences, a member of the AstraZeneca Group. As Vice President of Clinical Research and Development at Ardea, Dr. Storgard led the ZURAMPIC® global clinical program to successful U.S. and European regulatory approvals. Before joining Ardea in 2011, Dr. Storgard held senior positions in drug development and medical affairs at Prometheus Laboratories, Biogen Idec and Amgen, where he focused on biologic and small molecule development programs within the inflammation and oncology teams. He also completed a fellowship in Rheumatology at Scripps Clinic and Research Center and served as Senior Associate Consultant, Division of Rheumatology and Assistant Professor and Member of the Molecular Medicine Program at the Mayo School of Medicine, Mayo Clinic in Minnesota. Dr. Storgard received his M.D. and B.Sc. in biology from the University of Saskatchewan and is board-certified in Rheumatology and Internal Medicine.
Positions
- Company NameDesign Therapeutics, Inc.Stock CodeDSGNPositionChief Medical OfficerColleagues
- PSPratik ShahCo-Founder, President, CEO, Principal Financial Officer & Executive Chairperson
- SJSean JeffriesChief Operating Officer
- AZAseem Z. AnsariCo-Founder & Scientific Advisor
- JDJulie D. BurgessChief Accounting Officer
- JPJohn P. SchmidIndependent Director
- RWRodney W. LappeIndependent Director
- JDJustin D. GoverIndependent Director
